Cramer's Lightning Round: No to Viking Therapeutics
Summary by CNBC
2 Articles
2 Articles
Down 34%, Should You Buy the Dip on Viking Therapeutics? @themotleyfool #stocks $VKTX $NVO $TSLA $LLY $GS $PFE
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format.The biotech might eventually compete against pharma giants Eli Lilly and Novo Nordisk. 10 stocks we like better than Viking Therapeutics › Viking Therapeutics (NASDAQ: VKTX) has intrigued investors over the past year and a half because it's involved in a potential David and Goliath story. Today, pharma giants Eli Lilly and Novo Nordisk dom…
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium